CP
WGS icon

CenterBook Partners’s GeneDx Holdings WGS Stock Holding History

CenterBook Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+3,247
New +$185K 0.01% 672
2026
Q1 		– Sell
-17,893
Closed -$2.33M – 792
2025
Q4 		$2.33M Buy
+17,893
New +$2.46M 0.11% 243

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CenterBook Partners's WGS Position: Q2 2026 in Review

CenterBook Partners opened a new position in GeneDx Holdings (WGS) in Q2 2026: 3,247 shares worth $223K. The stake represents 0.01% of the portfolio and ranks #672 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in WGS as recently as Q4 2025.

CenterBook Partners first reported a position in WGS in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.33M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • CenterBook Partners held 3,247 shares of GeneDx Holdings worth $223K as of Q2 2026.
  • GeneDx Holdings was a new CenterBook Partners position in Q2 2026.
  • GeneDx Holdings made up 0.01% of CenterBook Partners's portfolio in Q2 2026, its #672 holding.
  • CenterBook Partners first reported a position in GeneDx Holdings in Q4 2025 and has held it in 2 quarters since.
  • CenterBook Partners's GeneDx Holdings position peaked at $2.33M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.